Scheltens P - Search Results

1

Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.

Kester MI, Verwey NA, van Elk EJ, Blankenstein MA, Scheltens P, van der Flier WM. Kester MI, et al. Among authors: scheltens p. Neurobiol Aging. 2011 Aug;32(8):1372-8. doi: 10.1016/j.neurobiolaging.2009.08.006. Epub 2009 Sep 11. Neurobiol Aging. 2011. PMID: 19748159

2

Biomarkers for Alzheimer's disease. Which way to go?

Teunissen CE, Scheltens P. Teunissen CE, et al. Among authors: scheltens p. Neurobiol Aging. 2004 Jul;25(6):695-6. doi: 10.1016/j.neurobiolaging.2003.08.013. Neurobiol Aging. 2004. PMID: 15165690 No abstract available.

3

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA. Schoonenboom NS, et al. Among authors: scheltens p. Clin Chem. 2005 Jan;51(1):189-95. doi: 10.1373/clinchem.2004.039735. Epub 2004 Nov 11. Clin Chem. 2005. PMID: 15539465

4

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.

Visser PJ, Scheltens P, Pelgrim E, Verhey FR; Dutch ENA-NL-01 Study Group. Visser PJ, et al. Among authors: scheltens p. Dement Geriatr Cogn Disord. 2005;19(2-3):126-33. doi: 10.1159/000082883. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627759

5

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.

Schoonenboom NS, Mulder C, Vanderstichele H, Pijnenburg YA, Van Kamp GJ, Scheltens P, Mehta PD, Blankenstein MA. Schoonenboom NS, et al. Among authors: scheltens p. Clin Chem. 2005 Jun;51(6):1057-60. doi: 10.1373/clinchem.2005.048629. Epub 2005 Apr 21. Clin Chem. 2005. PMID: 15845801 No abstract available.

6

A 24-year follow-up of body mass index and cerebral atrophy.

de Leeuw FE, van der Flier WM, Scheltens P. de Leeuw FE, et al. Among authors: scheltens p. Neurology. 2005 Jun 14;64(11):1990-1; author reply 1990-1. doi: 10.1212/wnl.64.11.1990. Neurology. 2005. PMID: 15955971 No abstract available.

7

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA, Mehta PD. Schoonenboom NS, et al. Among authors: scheltens p. Ann Neurol. 2005 Jul;58(1):139-42. doi: 10.1002/ana.20508. Ann Neurol. 2005. PMID: 15984010

8

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.

van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P. van der Flier WM, et al. Among authors: scheltens p. Stroke. 2005 Oct;36(10):2116-20. doi: 10.1161/01.STR.0000179092.59909.42. Epub 2005 Sep 1. Stroke. 2005. PMID: 16141425 Free article.

9

Infratentorial abnormalities in vascular dementia.

Bastos Leite AJ, van der Flier WM, van Straaten EC, Scheltens P, Barkhof F. Bastos Leite AJ, et al. Among authors: scheltens p. Stroke. 2006 Jan;37(1):105-10. doi: 10.1161/01.STR.0000196984.90718.8a. Epub 2005 Dec 8. Stroke. 2006. PMID: 16339463 Free article. Clinical Trial.

10

Multiple diagnostic tests are needed to assess multiple causes of dementia.

Olde Rikkert MG, van der Flier WM, de Leeuw FE, Verbeek M, Jansen RW, Verhey F, Scheltens P. Olde Rikkert MG, et al. Among authors: scheltens p. Arch Neurol. 2006 Jan;63(1):144-6. doi: 10.1001/archneur.63.1.144. Arch Neurol. 2006. PMID: 16401751 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,266 results

Search Page

Filters